Skip to main navigation

The link is opening in a new window or tab that may or may not accessible Opens an external site Opens an external site in a new window

Pre-Header Contact

800-449-3353 | custserv@rockwellmed.com |

Footer Socials

Pre-Header Menu

Careers | Contact Us

Client Header Links

Home
Our Company
Our Therapeutic Focus
Our Technology
Hemodialysis Concentrates
Investors

Investor Relations

Press Releases

Main navigation

Investor Home
Press Releases
Events & Presentations
Corporate Governance
Management
Annual Meeting
Financial Information
Stock Information
Investor FAQs
Contact Us
Shareholder Tools

Press Releases

Year

Nov 16, 2021

Rockwell Medical Study Demonstrates No Drug-drug Interaction Between Ferric Pyrophosphate Citrate and Unfractionated Heparin

PDF Version

Nov 15, 2021

Rockwell Medical, Inc. Provides Third Quarter 2021 Financial and Operational Update

PDF Version

Nov 12, 2021

Rockwell Medical Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

PDF Version

Nov 11, 2021

Rockwell Medical Submits Investigational New Drug Application with FDA for its Proposed Clinical Trial of FPC as a Treatment for Iron Deficiency Anemia in Patients Receiving Home Infusion

PDF Version

Nov 08, 2021

Rockwell Medical, Inc. to Report Third Quarter 2021 Financial and Operating Results on November 15, 2021

PDF Version

Nov 04, 2021

Rockwell Medical Presents Triferic® Real World Evidence Update at ASN Kidney Week 2021

PDF Version

Sep 09, 2021

Rockwell Medical, Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

PDF Version

Aug 19, 2021

Rockwell Medical, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

PDF Version

Aug 16, 2021

Rockwell Medical, Inc. Provides Second Quarter 2021 Financial and Operational Update

PDF Version

Jul 29, 2021

Rockwell Medical, Inc. to Report Second Quarter 2021 Financial and Operating Results on August 16, 2021

PDF Version

Pagination

Current page 1
Page 2
Page 3
Next page
Last page

Shareholder Tools

Snapshot

Email Alerts

RSS News Feeds

Have any questions?

Phone 248 432-1997

invest@rockwellmed.com

Client Header Links

Home
Our Company
Our Therapeutic Focus
Our Technology
Hemodialysis Concentrates
Investors
Contact

Footer Socials